Compare LXRX & CEPF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LXRX | CEPF |
|---|---|---|
| Founded | 1995 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 547.4M | 590.9M |
| IPO Year | 2000 | N/A |
| Metric | LXRX | CEPF |
|---|---|---|
| Price | $1.64 | $10.35 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $3.23 | N/A |
| AVG Volume (30 Days) | ★ 2.3M | 46.9K |
| Earning Date | 05-04-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 21.25 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $31,081,000.00 | N/A |
| Revenue This Year | $56.61 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $96.45 |
| Revenue Growth | ★ 2481.48 | N/A |
| 52 Week Low | $0.32 | $10.09 |
| 52 Week High | $1.83 | $10.67 |
| Indicator | LXRX | CEPF |
|---|---|---|
| Relative Strength Index (RSI) | 64.63 | 45.61 |
| Support Level | $1.07 | $10.34 |
| Resistance Level | $1.65 | $10.65 |
| Average True Range (ATR) | 0.10 | 0.04 |
| MACD | 0.02 | -0.01 |
| Stochastic Oscillator | 93.42 | 53.85 |
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.
Cantor Equity Partners IV Inc is a blank check company.